Why is "Beta thalassemia" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-26 00:53:26
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Beta-thalassemia (β-thalassemia) is an inherited blood disorder, a form of thalassemia resulting in variable outcomes ranging from clinically asymptomatic to severe anemia individuals. It is caused by reduced or absent synthesis of the beta chains of hemoglobin, the molecule that carries oxygen in the blood. Symptoms depend on the extent to which hemoglobin is deficient, and include anemia, pallor, tiredness, enlargement of the spleen, jaundice, and gallstones. In severe cases death ensues.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Dana-Farber Treats First Patient with Approved Gene Therapy for Beta Thalassemia - blog.dana-farber.org
-
Beta-Thalassemia Major With Iron Overload Cardiomyopathy and Refractory Cardiogenic Shock Requiring Mechanical Circulatory Support - JACC Journals
-
Assessment of health-related quality of life in transfusion dependent beta thalassemia - nature.com
-
Interpretable machine learning models for beta thalassemia prediction: an explainable AI approach for smart healthcare 5.0 - frontiersin.org
-
Living stronger with beta thalassemia through care and innovation - Bristol Myers Squibb
-
Impact of Beta-Thalassemia Trait on Clinical Outcomes and Treatment Response in Chronic Myeloid Leukemia - Cureus
-
FDA Approves Mitapivat as First Oral Treatment for Anemia in Adults With Alpha- or Beta-Thalassemia - Consultant360
-
‘Extremely encouraging’: Exa-cel benefits kids with sickle cell disease, beta thalassemia - Healio
-
Exa-cel shows complete success in early pediatric trials for sickle cell disease and beta-thalassemia - News-Medical
-
Vertex Will Seek Regulatory Approval for Casgevy in Younger Sickle Cell, Beta-Thalassemia Patients - Precision Medicine Online
-
[Beta-thalassemia and vitamin B12 deficiency and associated complement-mediated hemolysis]. - Physician's Weekly
-
Researcher Pioneers Faster, Cheaper Gene Therapy for Hemoglobin Disorders - UTHSC News
-
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy - BioSpace
-
Sickle cell and beta thalassemia: what are the treatment options and challenges? - UK Parliament
-
From Frequent Transfusions to a Cure for Beta Thalassemia - Healthier, Happy Lives Blog
-
Hemoglobin Sickle-Beta-Thalassemia With an Acute Crisis - Cureus
-
Eduardo’s inspiring journey of hope and support with beta thalassemia - Bristol Myers Squibb
-
Challenges and opportunities in delivering gene therapies for sickle cell disease and beta thalassemia - News-Medical
-
A Case of Sickle Cell Beta Thalassemia and Recurrent Septicemia - Cureus
-
Diagnostic Accuracy of the Patra Index and Red Cell Distribution Width Index in Distinguishing Beta-Thalassemia Trait From Iron Deficiency Anemia: A Retrospective Comparative Study - Cureus
-
FDA Approves Mitapivat for Thalassemia-Related Anemia - MedPage Today
-
Gene therapy for sickle cell and β-thalassemia works by disrupting three-dimensional genome structure - St. Jude Children's Research Hospital
-
Exa-cel dramatically improves quality of life for sickle cell disease, beta-thalassemia - Healio
-
Gene therapy leads to improved quality of life in patients with sickle cell disease and beta thalassemia - Medical Xpress
-
Deferoxamine Intradermal Delivery Patch For Treatment Of A Beta Thalassemia Wound - Stanford Medicine
-
Ischemic Stroke as the Initial Presentation of Sickle Beta Thalassemia in an Adolescent: A Case Report - Cureus
-
Gene Therapy Linked to Improved Quality of Life in Blood Disorder Patients - Technology Networks
-
Two New Cures for Transfusion-Dependent Beta Thalassemia - HealthCentral
-
Experts Reflect on, Look Toward the Future of Fetal Hemoglobin Reactivation Therapies - ashpublications.org
-
New FDA-approved pill targets anemia in adults with alpha or beta thalassemia - Stock Titan
-
Study of Thyroid Function in Children With Beta-Thalassemia Major - Cureus
-
Basrah Score: a novel machine learning-based score for differentiating iron deficiency anemia and beta thalassemia trait using RBC indices - frontiersin.org
-
A comprehensive case study of deep learning on the detection of alpha thalassemia and beta thalassemia using public and private datasets - nature.com
-
Betibeglogene autotemcel in the treatment of β-thalassemia — a systematic review - Via Medica Journals
-
Questions of Access: Gene Therapy’s Next Chapter in β-Thalassemia - CGTLive®
-
Gene Therapy 'Transformed Lives' for Patients With Blood Disorders - MedPage Today
-
Which Gene Therapy Technology Wins? New Data from Spherix - GlobeNewswire
-
Zydus Secures USFDA Orphan Drug Designation For Desidustat In Beta-Thalassemia - BW Healthcare World
-
USFDA Approves Agios Pharma's Aqvesme for Alpha, Beta Thalassemia Anemia - Medical Dialogues
-
Zydus gets USFDA's orphan drug designation for beta-thalassemia product - The Economic Times
-
Correction to “Efficacy and Safety of Early-Start Deferiprone in Infants and Young Children With Transfusion-Dependent Beta Thalassemia: Evidence for Iron Shuttling to Transferrin in a Randomized, Double-Blind, Placebo-Controlled, Clinical Trial (START)” - Wiley Online Library
-
First gene editing therapy to treat beta thalassemia and severe sickle cell disease - European Medicines Agency (EMA)
-
A Case Report of Choroidal Neovascularization Secondary to Angioid Streaks Associated With Beta Thalassemia - Cureus
-
Unexpectedly Low HbA1c in a Patient With Newly Diagnosed Diabetes Mellitus and Thalassemia Trait: A Case Report - Cureus
-
Zydus receives USFDA approval for beta-thalassemia drug Desidustat - Healthcare Radius
-
Evolving Needs of People with Beta Thalassemia - Bristol Myers Squibb
-
Treating Transfusion-Dependent Beta Thalassemia - HealthCentral
-
The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells - frontiersin.org
-
First Patient to Receive Gene Therapy ‘Cure’ for Beta-Thalassemia Living Pain-Free - Good News Network
-
Genetic Study for Identifying Beta Thalassemia Trait in Relatives of Children with Beta Thalassemia Major - Cureus
-
Life-Changing Gene Therapy for Beta-Thalassemia Patients with Jennifer Schneiderman, MD - Northwestern Feinberg School of Medicine
-
FDA expands approval of CRISPR-based medicine to treat beta thalassemia - statnews.com
-
Beta-Thalassemia in Adulthood Previously Suspected as Treatment-Resistant Iron Deficiency Anemia: A Case Report - Cureus
-
New study to track childhood blood disorders - BBC
-
Personal Story: Radhika Sawh - cdc.gov
-
Growing up with beta-thalassemia: Taking charge of your care - Bristol Myers Squibb
-
Agios drug reduces blood transfusions in patients with beta-thalassemia, study shows - statnews.com
-
Novel Beta-Thalassemia Deletion Removes Entire Beta-Globin Gene - Hematology Advisor
-
San Diego girl with 199 blood transfusions draws awareness to rare disorder - cbs8.com
-
Yuetong’s Journey Battling Beta Thalassemia While Pursuing His Passion - Bristol Myers Squibb
-
How Thalassemia Affects Your Body - HealthCentral
-
Gene therapy a viable cure for beta thalassemia, study says - nature.com
-
Gene Therapy Promotes Transfusion Independence for Severe Beta-Thalassemia - Northwestern University
-
Reduced Exercise Capacity Associated With Cardiac Iron Overload in Beta-Thalassemia Major - Hematology Advisor
-
LLUH first in Southern California to offer beta thalassemia gene therapy - Loma Linda University
-
Bleeding and Thrombotic Risks in Young Patients With Beta-Thalassemia Major - Hematology Advisor
-
Successful treatment of transfusion-dependent β-thalassemia: multiple paths to reach potential cure - nature.com
-
Cell therapy weekly: FDA authorizes CASGEVY for beta thalassemia - RegMedNet
-
Bluebird wins U.S. approval for a gene therapy to treat patients with a rare blood disorder - statnews.com
-
Rare Co-occurrence of Beta-Thalassemia and Pseudoxanthoma elasticum: Novel Biomolecular Findings - frontiersin.org
-
The genetic architecture of the β-globin chain in individuals with and without sickle cell disease in Nigeria: A case for beta thalassemia? - medrxiv.org
-
Exploring the Clinical and Hematological Characteristics of Beta-Thalassemia Trait: A Comprehensive Analysis in a Tertiary Care Hospital Setting - Cureus
-
Vertex, CRISPR's gene-editing therapy Casgevy wins early FDA nod to treat beta thalassemia - Fierce Pharma
-
Clinical Roundup: Gene-Edited Therapies for Beta Thalassemia - CRISPR Medicine News
-
The Silent Carrier of Beta Thalassemia - The New England Journal of Medicine
-
You Make the Call: How would you manage a patient with a history of beta thalassemia major and pancytopenia who requires frequent blood transfusions? | ASH Clinical News | American Society of Hematology - ashpublications.org
-
Reducing Transfusion Burden and Addressing Unmet Needs in Beta Thalassemia - Hematology Advisor
-
EU Approves Luspatercept for Anemia in Patients with Non–Transfusion-Dependent Beta Thalassemia - OncLive
-
CRISPR Therapy for Beta Thalassemia Obtains FDA Rare Paediatric Disease Designation - CRISPR Medicine News
-
First patient to receive gene therapy treatment developed at Children's Hospital of Philadelphia living pain-free - CBS News
-
Luspatercept Elicited Durable Erythroid Response in NTD Beta-Thalassemia - Hematology Advisor
-
Beta Thalassemia Market Size to Reach USD 822.5 Million by 2034, Impelled by Novel Treatment Methods - BioSpace
-
Overview of Beta Thalassemia - OncLive
-
Lipid Profiles in Beta-Thalassemia With IVS Mutations and Hydroxyurea Therapy - Hematology Advisor
-
Beta Thalassemia: clinical trial provides encouraging evidence for efficacy of gene therapy - fondazionetelethon.it
-
SurvivorNet: Perlmutter Cancer Center Hematologist–Oncologist Discusses New Treatment for Beta Thalassemia - NYU Langone Health
-
Orchard’s Gene Therapy Shows Potential in Treating Patients with Beta Thalassemia - Labiotech.eu
-
FDA widens approval of Vertex’s CRISPR medicine to treat beta thalassemia - BioPharma Dive
-
Mutational analysis of hemoglobin genes and functional characterization of detected variants, through in-silico analysis, in Pakistani beta-thalassemia major patients - nature.com
-
Beta Thalassemia Carriers May Be More Susceptible to Severe COVID-19 - Hematology Advisor
-
Thalidomide Appears Safe, Effective in Transfusion-Dependent Beta-Thalassemia - Hematology Advisor
-
New Insights Into Pathophysiology of β-Thalassemia - frontiersin.org
-
Arrhythmias During Pregnancy: Ventricular Tachycardia in the Setting of Maternal Beta Thalassemia Minor - Cureus
-
Patients with rare blood disorder benefit from Bluebird gene therapy while denied access in Europe - statnews.com
-
United Kingdom approves first-ever CRISPR treatment, a cure for sickle cell disease and beta thalassemia - Science | AAAS
-
Interim Analysis Shows Exa-Cel Leads to Transfusion Independence in Beta-Thalassemia - Docwire News
-
Bluebird Bio Launches First Gene Therapy for Beta Thalassemia in Germany - Labiotech.eu
-
Oakland Hospital First in West to Pioneer Beta Thalassemia Drug - UC San Francisco
-
Two Daughters, a Rare Blood Disorder and a Fairytale Cure - UC San Francisco
-
FDA Approves Vertex, CRISPR’s Casgevy to Treat Beta Thalassemia - BioSpace
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.